2251 — Beijing Airdoc Technology Co Balance Sheet
0.000.00%
- HK$1.21bn
- HK$394.43m
- CNY156.37m
- 32
- 18
- 57
- 25
Annual balance sheet for Beijing Airdoc Technology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 375 | 1,785 | 1,413 | 1,142 | 775 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 19.8 | 37.3 | 70.7 | 89 | 46.5 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 409 | 1,846 | 1,676 | 1,282 | 894 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 23.2 | 45 | 33.1 | 28.4 | 18.9 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 436 | 1,894 | 1,740 | 1,685 | 1,411 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 24.9 | 70.8 | 64.7 | 110 | 122 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 27.5 | 74.2 | 73.8 | 145 | 143 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 408 | 1,820 | 1,666 | 1,540 | 1,269 |
Total Liabilities & Shareholders' Equity | 436 | 1,894 | 1,740 | 1,685 | 1,411 |
Total Common Shares Outstanding |